Find Legal Topics > Drugs Laws > Mirapex Lawsuit

Mirapex Lawsuit

 

A brief guide to filing a Mirapex lawsuit

 

Since its approval by the 1997 as a medication for people suffering from Parkinson's disease, reports of serious Mirapex side effects and litigation have increased. Multiple studies have established a link between treatment with the medication and the loss of impulse control, leading to behaviors including compulsive gambling.

 

Due to the volume of litigation seeking a Mirapex settlement, all such lawsuits are now being handled under the process of multidistrict litigation. This is a procedure in which a federal court hears multiple cases concerning the same complaint. In 2007, the federal district court of Minnesota was appointed to oversee the progress every Mirapex lawsuit.

 

By this point, many studies had demonstrated that Mirapex side effects conclusively included a lack of impulse control. A 2005 review of FDA reports of adverse effects found that 39 users of the drug had reported the development of pathological gambling habits. A 2009 Mayo Clinic provided further justification for people who wished to file a Mirapex lawsuit. While none of the patients taking the medication Carbidopa developed such symptoms, seven users of the medication developed these Mirapex side effects.

 

The first Mirapex lawsuit in the multidistrict litigation was heard in 2008. The plaintiff said he began taking the medication but did not develop compulsive gambling Mirapex side effects until 2002. As part of his Mirapex lawsuit, the plaintiff noted that his gambling continued for three months after he stopped treatment in November 2005. He was awarded a Mirapex settlement of $8.2 million in June 2008.

 

The success of this Mirapex lawsuit was due to several factors. Most importantly, while seeking a Mirapex settlement, the plaintiff's lawyers pointed to the studies and FDA reports regarding gambling behaviors. Their Mirapex lawsuit argued that these studies should have spurred the drug's manufacturers to conduct tests to investigate this risk. Furthermore, the complaint seeking a Mirapex settlement noted that the company did not provide any warning label information of this possible development until March 2005. This justified the Mirapex lawsuit in arguing the drug information provided was not sufficient for patients to make an informed decision about treatment.

 

The results of subsequent suits seeking a Mirapex settlement have not been made public. Litigation regarding Mirapex side effects is still being handled by the same federal court. It is unclear when every suit seeking a Mirapex settlement will be concluded. However, the statute of limitations to pursue compensation for Mirapex side effects that occurred before March 2005 will have expired for nearly all plaintiffs. Therefore, seeking a Mirapex settlement for such claims is no longer possible.

 

Recent studies have suggested that Mirapex side effects concerning the risk of cardiac failure are greater than suggested by the manufacturer. It may be possible to seek a Mirapex settlement if you have experienced a heart attack or other adverse effect related to such treatment. However, no litigation concerning such Mirapex side effects is known to have been successful at present.

 

Related Topics